Correlation Between Pieris Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Pieris Pharmaceuticals and Apellis Pharmaceuticals
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pieris and Apellis is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Pieris Pharmaceuticals is 1.61 times more volatile than Apellis Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 5,036 in Apellis Pharmaceuticals on August 29, 2024 and sell it today you would lose (1,622) from holding Apellis Pharmaceuticals or give up 32.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| Apellis Pharmaceuticals |
Pieris Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Pieris Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
| Apellis Pharmaceuticals vs. Bright Minds Biosciences | Apellis Pharmaceuticals vs. HP Inc | Apellis Pharmaceuticals vs. Intel | Apellis Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |